Rock Springs Capital Management LP Prothena Corp Public LTD CO Call Options Transaction History

Rock Springs Capital Management LP

  • $2.94 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$12.7 - $15.79 $1.08 Million - $1.34 Million
-85,000 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$10.99 - $44.21 $549,500 - $2.21 Million
-50,000 Reduced 37.04%
85,000 $1.24 Million
Q1 2018

May 15, 2018
BUY
$27.95 - $45.04 $3.07 Million - $4.95 Million
110,000 Added 440.0%
135,000 $4.96 Million
Q4 2017

Feb 14, 2018
BUY
$35.44 - $63.76 $886,000 - $1.59 Million
25,000
25,000 $937,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $561M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email